MIAMI, FL – March 7, 2017 – Robert Udelsman, M.D., MBA, FACS, FACE, has joined the growing team of cancer care specialists at Miami Cancer Institute at Baptist Health South Florida as chief of endocrine surgery and director of the Endocrine Neoplasia Institute.

Dr. Udelsman comes to Miami Cancer Institute from Yale University School of Medicine, where he served as surgeon-in-chief at Yale-New Haven Hospital since 2001. Renowned for his innovative and highly successful surgical approach to performing thyroid and parathyroid operations, he has dedicated much of his career to the development of minimally invasive endocrine procedures, performing more than 6,000 thyroid and 2,500 parathyroid procedures to date. He was one of the first in the world to perform minimally invasive parathyroidectomy and the first in the U.S. to perform thyroid and parathyroidectomies via the mouth, avoiding visible scarring. He also was an early adopter of laparoscopic adrenalectomy.

Dr. Udelsman is board-certified in surgery. He completed his medical training at George Washington University School of Medicine and Health Sciences and his surgical residency and chief residency at the Johns Hopkins Hospital in Baltimore. He also completed three fellowships: surgical oncology at the National Cancer Institute; endocrinology at the National Institute of Child Health and Human Development; and gastrointestinal surgery at Johns Hopkins Hospital.

“Dr. Udelsman is one of the most highly recognized and experienced endocrine surgeons in the world,” said Michael J. Zinner, M.D., founding CEO and executive medical director of Miami Cancer Institute. “His background, combined with the comprehensive resources available at Miami Cancer Institute, takes us yet another step closer to delivering on our promise to provide world-class, destination cancer care for all disease sites, close to home.”

During his tenure at Yale, Dr. Udelsman served as president of the American Association of Endocrine Surgeons and the International Association of Endocrine Surgeons. His clinical research results have appeared in more than 300 publications. He has been honored with numerous awards and is a member of 30 national and international professional societies and seven scientific journal editorial boards.

About Miami Cancer Institute
Baptist Health South Florida is developing Miami Cancer Institute into a destination cancer center known for its leading clinical care, exceptional patient experience, advanced clinical research and state-of-the-art technology – including the first proton therapy center in South Florida, Latin America and the Caribbean. To accelerate its mission of hope, caring and innovation, Miami Cancer Institute has joined the Memorial Sloan Kettering Cancer Alliance, a meaningful relationship that enables patients with cancer access to potential breakthrough therapies in South Florida. For more information, visit MiamiCancerInstitute.com.

Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with seven hospitals (Baptist Hospital, Baptist Children’s Hospital, Doctors Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital), nearly 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence. A not-for-profit organization supported by philanthropy and committed to our faith-based charitable mission of medical excellence, Baptist Health has approximately 16,000 employees and 2,300 affiliated physicians. Baptist Health South Florida has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net and connect with us on Facebook at facebook.com/BaptistHealthSF and on Twitter and Instagram @BaptistHealthSF.